Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Progressive multifocal leukoencephalopathy associated with elranatamab therapy in relapsed/refractory multiple myeloma.
Tansuhan Çetiner, Merve Çağla Bilek, Selin Arslan Kirezli, Gökhan Yavuz Üçüncü, Ünal Ataş, Utku Iltar, Orhan Kemal Yücel, Özlem Çakin, Kamil Karaali, Ozan Salim
Published: 202610.1177/10781552261417343
Abstract
IntroductionElranatamab, a bispecific antibody targeting B-cell maturation antigen (BCMA) and CD3, has demonstrated remarkable efficacy in relapsed or refractory multiple myeloma (RRMM). With the growing clinical use of BCMA-directed bispecific antib…
Preview only. Read the full abstract at the source